XNZW:XETRA:XETRA-Xtrackers World Net Zero Pathway Paris Aligned UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 44.425

Change

+0.02 (+0.03)%

Market Cap

USD 0.03B

Volume

112.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.20 (-0.39%)

USD 509.68B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.08 (-0.47%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

N/A

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.18 (-0.68%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.12 (-0.51%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-0.24 (-0.17%)

USD 100.74B
JARI:XETRA Amundi Index Solutions - Amund..

-0.14 (-0.32%)

USD 100.71B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.25 (-0.50%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.16 (-0.21%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.08 (-0.35%)

USD 79.79B

ETFs Containing XNZW:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.80% 68% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.80% 68% D+ 67% D+
Trailing 12 Months  
Capital Gain 22.21% 74% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.21% 74% C 74% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.53% 61% D- 60% D-
Dividend Return 6.53% 60% D- 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.89% 66% D+ 73% C
Risk Adjusted Return 73.44% 89% A- 89% A-
Market Capitalization 0.03B 17% F 15% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.